Sudeep Pharma share price extends rally after strong listing. Should investors buy, sell or hold the stock?

Sudeep Pharma IPO listing was better than Street estimates as was indicated by the grey market premium (GMP). Ahead of the debut, Sudeep Pharma IPO GMP today signalled a listing gain of nearly 20%.

Leave a Comment